S&P 500 slips after report on coronavirus drug trial
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
Gilead Sciences (GILD) Remdesivir China Results 'Very Sobering' - Baird
April 23, 2020 1:34 PM EDTBaird analyst Brian Skorney weighed in on Gilead Sciences (NASDAQ: GILD) related to news that a China trial of severe patients showed remdesivir didn't improve patients' condition.
Skorney commented, "This afternoon, an abstract leaked indicating that Gilead's remdesivir failed to provide a benefit... More
Domino's Pizza (DPZ) Tops Q1 EPS by 75c, Revenues Beat; 'Withdraws 2-3 Year Outlook'
April 23, 2020 7:32 AM EDTDomino's Pizza (NYSE: DPZ) reported Q1 EPS of $3.07, $0.75 better than the analyst estimate of $2.32. Revenue for the quarter came in at $873.1 million versus the consensus estimate of $868.67 million.
"In a time of unprecedented change in our industry, I am pleased to report that Domino's is in a... More
Target (TGT) Extends Decline, Down 5.5% Pre-Market
April 23, 2020 7:17 AM EDTTarget (NYSE: TGT) Extends Decline, Down 5.5% Pre-Market
... More